TagBiocad

According to the sanitary watchdog, there will be 150 volunteers older than 60 overall.

Earlier, the anti-coronavirus task force in the Tomsk Region said five out of the 42 medics vaccinated against COVID-19 in the region, tested positive for the novel coronavirus infection.

Post-registration trials phase of the EpiVacCorona vaccine will begin in November-December on 40,000 volunteers, according to the center’s director general.

The new condition, which is caused by genetic mutations, has shown a particularly high death rate, as patients were not responding to any currently available treatments, the researchers said.

Overall, both vaccine formulations turned out to be approximately equally effective causing all volunteers to develop antibodies to the coronavirus and teaching T-cells to recognize this threat.

As early as today Moscow residents can apply to participate in the study and be the first to obtain the vaccine. The permission to release batch of Sputnik V vaccine for civilian use may be granted next week

According to the industry and trade minister, the company was chosen at an early stage, when the vaccine was in the works.

The vaccine is designated for the 18-60 age group.

A mere week after Russia registered the world’s first coronavirus vaccine, the ‘Vector’ virology center in Novosibirsk has announced that an entirely different Covid-19 solution is entering the second stage of clinical trials.

Israel is also considering joining the clinical trials of the Russian vaccine.

To boldly go where no vaccine has gone before? A new video promoting Sputnik V, Russia’s vaccine against Covid-19, envisions the drug as its space namesake zapping into oblivion a giant coronavirus engulfing the entire planet.

Valuable experience from working on vaccines for Ebola and MERS made it possible to roll out a drug against the novel coronavirus a lot quicker than many expected, the head of the research center behind Sputnik V told RT.

The Russian Health Ministry announced on Saturday that production of the world’s first registered coronavirus vaccine has begun. It’s been named ‘Sputnik V’ after the famed space satellite, launched by Moscow in 1957.

The Russian vaccine comes as countries around the world are bracing for the possibility of a second wave of coronavirus infections. The initial wave has already infected over 20 million people and claimed the lives of over 736,000, decimating many countries’ economies in the process.

The requests for access to the Russian pharmaceutical development emerged after President Vladimir Putin announced that the first vaccine against the coronavirus had been officially registered in the country after passing trials and that production would soon commence.